November 15, 2024
Trinity Biotech Announces Q3 2024 Financial Results
DUBLIN, Ireland (November 15, 2024) – Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the Company’s results for the quarter ended September 30, 2024.